Abstract
Eighteen patients with advanced breast cancer refractory to combination chemotherapy with 5‐FU, Adriamycin, Cytoxan (FAC) were treated with methotrexate 30 to 40 mg/m2 iv and vincristine 1.5 mg/m2 iv at weekly intervals. Of 17 evaluable patients, 4 (23%) achieved a partial remission with a median duration of remission of 6 months and a median survival of 10 months. In another seven of seventeen patients (41%) the disease remained stable. Toxicity was minimal.
Original language | English (US) |
---|---|
Pages (from-to) | 32-34 |
Number of pages | 3 |
Journal | Cancer |
Volume | 44 |
Issue number | 1 |
DOIs | |
State | Published - Jul 1979 |
ASJC Scopus subject areas
- Oncology
- Cancer Research